What is the future of the gut microbiota-related treatment? Toward modulation of microbiota in preventive and therapeutic medicine

Frontiers in Medicine

Volumn 1, Issue JUL, 2014, Pages

  Zatorski, Hubert ^a   Fichna, Jakub ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Fecal transplant; Future treatment of gastrointestinal diseases; Gut microbiota; IBD; Probiotic

Indexed keywords

EID: 84956482811     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2014.00019     Document Type: Note

References (13)

1. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature (2012) 486:222-7. doi:10.1038/nature11053
2. Arumugam M, Raes J, Pelletier E, Le PD, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature (2011) 473:174-80. doi:10.1038/nature09944
3. Salonen A, Salojarvi J, Lahti L, de Vos WM. The adult intestinal core microbiota is determined by analysis depth and health status. Clin Microbiol Infect (2012) 18(Suppl 4):16-20. doi:10.1111/j.1469-0691.2012.03855.x
4. Marques TM, Cryan JF, Shanahan F, Fitzgerald GF, Ross RP, Dinan TG, et al. Gut microbiota modulation and implications for host health: dietary strategies to influence the gut-brain axis. Innov Food Sci Emerg Technol (2014) 22:239-47. doi:10.1016/j.ifset.2013.10.016
5. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A (2010) 107:14691-6. doi:10.1073/pnas.1005963107
6. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 104:13780-5. doi:10.1073/pnas.0706625104
7. Sokol H, Seksik P. The intestinal microbiota in inflammatory bowel diseases: time to connect with the host. Curr Opin Gastroenterol (2010) 26:327-31. doi:10.1097/MOG.0b013e328339536b
8. Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut (2013). doi:10.1136/gutjnl-2013-304833
9. Walsh CJ, Guinane CM, O'Toole PW, Cotter PD. Beneficial modulation of the gut microbiota. FEBS Lett (2014). doi:10.1016/j.febslet.2014.03.035
10. Saulnier DM, Spinler JK, Gibson GR, Versalovic J. Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol (2009) 20:135-41. doi:10.1016/j.copbio.2009.01.002
11. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2010) 59:325-32. doi:10.1136/gut.2008.167270
12. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev (2011) 3:CD005496. doi:10.1002/14651858.CD005496.pub3
13. Pineiro M, Asp NG, Reid G, Macfarlane S, Morelli L, Brunser O, et al. FAO technical meeting on prebiotics. J Clin Gastroenterol (2008) 42(Suppl 3 Pt 2):S156-9. doi:10.1097/MCG.0b013e31817f184e